Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 475

1.

Protocol of the European Registry on the management of Helicobacter pylori infection (Hp-EuReg).

McNicholl AG, O'Morain CA, Megraud F, Gisbert JP; As Scientific Committee of the Hp-Eureg on Behalf of the National Coordinators.

Helicobacter. 2019 Jul 8:e12630. doi: 10.1111/hel.12630. [Epub ahead of print]

PMID:
31282060
2.

Efficacy of a tailored PCR-guided triple therapy in the treatment of Helicobacter pylori infection.

Delchier JC, Bastuji-Garin S, Raymond J, Megraud F, Amiot A, Cambau E, Burucoa C; HELICOSTIC Study Group.

Med Mal Infect. 2019 Jun 27. pii: S0399-077X(18)30185-9. doi: 10.1016/j.medmal.2019.06.001. [Epub ahead of print]

PMID:
31257067
3.

Prevalence of Helicobacter pylori infection and antibiotic resistance profile in Armenia.

Gemilyan M, Hakobyan G, Benejat L, Allushi B, Melik-Nubaryan D, Mangoyan H, Laur A, Daguerre E, Grigoryan E, Megraud F.

Gut Pathog. 2019 Jun 8;11:28. doi: 10.1186/s13099-019-0310-0. eCollection 2019.

4.

Source attribution of Campylobacter jejuni shows variable importance of chicken and ruminants reservoirs in non-invasive and invasive French clinical isolates.

Berthenet E, Thépault A, Chemaly M, Rivoal K, Ducournau A, Buissonnière A, Bénéjat L, Bessède E, Mégraud F, Sheppard SK, Lehours P.

Sci Rep. 2019 May 30;9(1):8098. doi: 10.1038/s41598-019-44454-2.

5.

Bismuth Concentrations in Patients Treated in Real-Life Practice with a Bismuth Subcitrate-Metronidazole-Tetracycline Preparation: The SAPHARY Study.

Guiard E, Lelievre B, Rouyer M, Zerbib F, Diquet B, Mégraud F, Tison F, Bignon E, Lassalle R, Droz-Perroteau C, Moore N, Blin P.

Drug Saf. 2019 Aug;42(8):993-1003. doi: 10.1007/s40264-019-00821-6.

PMID:
31069703
6.

Orthotopic Patient-Derived Xenografts of Gastric Cancer to Decipher Drugs Effects on Cancer Stem Cells and Metastatic Dissemination.

Giraud J, Bouriez D, Seeneevassen L, Rousseau B, Sifré E, Giese A, Mégraud F, Lehours P, Dubus P, Gronnier C, Varon C.

Cancers (Basel). 2019 Apr 19;11(4). pii: E560. doi: 10.3390/cancers11040560.

7.

Combination of Bismuth and Standard Triple Therapy Eradicates Helicobacter pylori Infection in More than 90% of Patients.

McNicholl AG, Bordin DS, Lucendo A, Fadeenko G, Fernandez MC, Voynovan I, Zakharova NV, Sarsenbaeva AS, Bujanda L, Perez-Aisa Á, Vologzhanina L, Zaytsev O, Ilchishina T, Coba C, Lasala JP, Alekseenko S, Modolell I, Molina-Infante J, Ruiz-Zorrilla Lopez R, Alonso-Galan H, Moreno NF, Hinojosa J, Santaella I, Varela P, Gonzalez-Cordero PL, Barrio J, Dominguez-Jimenez JL, Nuñez O, Alcedo J, Nyssen OP, Caldas M, Donday MG, Shvetz O, Megraud F, O'Morain C, Gisbert JP.

Clin Gastroenterol Hepatol. 2019 Apr 10. pii: S1542-3565(19)30369-6. doi: 10.1016/j.cgh.2019.03.048. [Epub ahead of print]

PMID:
30978536
8.

Detecting both current and prior Helicobacter pylori infection is important to assess its impact on dementia.

Roubaud-Baudron C, Mégraud F, Salles N, Dartigues JF, Letenneur L.

Alzheimers Dement. 2019 May;15(5):721-722. doi: 10.1016/j.jalz.2018.12.020. Epub 2019 Mar 8. No abstract available.

PMID:
30853466
9.

Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.

Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, Garrido M, Kikuste I, Megraud F, Matysiak-Budnik T, Annibale B, Dumonceau JM, Barros R, Fléjou JF, Carneiro F, van Hooft JE, Kuipers EJ, Dinis-Ribeiro M.

Endoscopy. 2019 Apr;51(4):365-388. doi: 10.1055/a-0859-1883. Epub 2019 Mar 6.

10.

European Registry on the management of Helicobacter pylori infection (Hp-EuReg): analysis of 2360 patients receiving first-line therapy in Russia.

Bordin DS, Embutnieks YV, Vologzhanina LG, Il'chishina TA, Voinovan IN, Sarsenbaeva AS, Alekseenko SA, Zaitsev OV, Abdulkhakov RA, Osipenko MF, Livzan MA, Tsukanov VV, Burkov SG, Bakulina NV, Dekhnich NN, Tarasova LV, Plotnikova EY, Maev IV, Kucheryavyi YA, Baryshnikova NV, Butov MA, Kolbasnikov SV, Pakhomova AL, Zhestkova TV, Baranovskii AY, Abdulkhakov SR, Ageeva EA, Lyalyukova EA, Vasyutin AV, Golubev NN, Savilova IV, Morkovkina LV, Kononova AG, Megraud F, O'Morain C, Ramas M, Nyssen OP, McNicholl AG, Gisbert JP.

Ter Arkh. 2018 Feb 15;90(2):35-42. doi: 10.26442/terarkh201890235-42.

PMID:
30701770
11.

Metformin can inhibit Helicobacter pylori growth.

Courtois S, Bénéjat L, Izotte J, Mégraud F, Varon C, Lehours P, Bessède E.

Future Microbiol. 2018 Nov;13:1575-1583. doi: 10.2217/fmb-2018-0184. Epub 2018 Nov 13.

PMID:
30421627
12.

Antibiotic Resistance Is the Key Element in Treatment of Helicobacter pylori Infection.

Mégraud F.

Gastroenterology. 2018 Nov;155(5):1300-1302. doi: 10.1053/j.gastro.2018.10.012. Epub 2018 Oct 8. No abstract available.

PMID:
30308190
13.

Diagnosis of Helicobacter pylori infection.

Skrebinska S, Mégraud F, Bessède E.

Helicobacter. 2018 Sep;23 Suppl 1:e12515. doi: 10.1111/hel.12515. Review.

PMID:
30203584
14.

Real-time PCR for Helicobacter pylori diagnosis. The best tools available.

Bénéjat L, Ducournau A, Lehours P, Mégraud F.

Helicobacter. 2018 Oct;23(5):e12512. doi: 10.1111/hel.12512. Epub 2018 Aug 28.

PMID:
30156040
15.

A GWAS on Helicobacter pylori strains points to genetic variants associated with gastric cancer risk.

Berthenet E, Yahara K, Thorell K, Pascoe B, Meric G, Mikhail JM, Engstrand L, Enroth H, Burette A, Megraud F, Varon C, Atherton JC, Smith S, Wilkinson TS, Hitchings MD, Falush D, Sheppard SK.

BMC Biol. 2018 Aug 2;16(1):84. doi: 10.1186/s12915-018-0550-3.

16.

Campylobacter infection in adult patients with primary antibody deficiency.

Dion J, Malphettes M, Bénéjat L, Mégraud F, Wargnier A, Boutboul D, Galicier L, Le Moing V, Giraud P, Jaccard A, Nove-Josserand R, Fieschi C, Oksenhendler E, Gérard L; DEFI study group.

J Allergy Clin Immunol Pract. 2019 Mar;7(3):1038-1041.e4. doi: 10.1016/j.jaip.2018.06.014. Epub 2018 Jul 6. No abstract available.

PMID:
29981862
17.

Whole-Genome Sequence Analysis of Multidrug-Resistant Campylobacter Isolates: a Focus on Aminoglycoside Resistance Determinants.

Fabre A, Oleastro M, Nunes A, Santos A, Sifré E, Ducournau A, Bénéjat L, Buissonnière A, Floch P, Mégraud F, Dubois V, Lehours P.

J Clin Microbiol. 2018 Aug 27;56(9). pii: e00390-18. doi: 10.1128/JCM.00390-18. Print 2018 Sep.

18.

Identification of Streptococcus sinensis from a patient with endocarditis using MALDI-TOF mass spectrometry, 16S rDNA- and sodA-based phylogeny.

Goret J, Baudinet T, Camou F, Issa N, Gaillard P, Wirth G, Greib C, Barandon L, Mégraud F, Bébéar C, Peuchant O, Ménard A.

J Microbiol Immunol Infect. 2019 Jun;52(3):507-509. doi: 10.1016/j.jmii.2018.04.004. Epub 2018 May 29. No abstract available.

19.

Epidemiologic cutoff values to separate wild-type from non-wild-type Campylobacter fetus to ciprofloxacin.

Bénéjat L, Sifré E, Domingues Martins C, Ducournau A, Buissonnière A, Bessède E, Mégraud F, Lehours P.

Diagn Microbiol Infect Dis. 2018 Oct;92(2):164-167. doi: 10.1016/j.diagmicrobio.2018.05.012. Epub 2018 May 18.

PMID:
29884563
20.

A new kit to detect Campylobacter species in stool specimens: the Orion GenRead Campylobacter®.

Buissonnière A, Bénéjat L, Charron P, Bessède E, Lehours P, Valdenaire G, Richer O, Mégraud F.

Eur J Clin Microbiol Infect Dis. 2018 Aug;37(8):1585-1587. doi: 10.1007/s10096-018-3288-5. Epub 2018 Jun 3.

PMID:
29862421
21.

Impact of the introduction of a nucleic acid amplification test for Clostridium difficile diagnosis on stool rejection policies.

Goret J, Blanchi J, Floch P, Peuchant O, Chrisment D, Sanchez R, Biessy H, Lemarié R, Leyssene D, Loutfi B, Mimouni S, Flao T, Bébéar C, Mégraud F.

Gut Pathog. 2018 May 30;10:19. doi: 10.1186/s13099-018-0245-x. eCollection 2018.

22.

Molecular detection of mutations involved in Helicobacter pylori antibiotic resistance in Algeria.

Bachir M, Allem R, Benejat L, Tifrit A, Medjekane M, Drici AE, Megraud F, Douidi KT.

J Antimicrob Chemother. 2018 Aug 1;73(8):2034-2038. doi: 10.1093/jac/dky167.

PMID:
29762682
23.

A representative overview of the genetic diversity and lipooligosaccharide sialylation in Campylobacter jejuni along the broiler production chain in France and its comparison with human isolates.

Thépault A, Guyard-Nicodème M, Rose V, Quesne S, Queguiner M, Houard E, Mégraud F, Rivoal K, Chemaly M.

Int J Food Microbiol. 2018 Jun 2;274:20-30. doi: 10.1016/j.ijfoodmicro.2018.03.010. Epub 2018 Mar 20.

PMID:
29579648
24.

Helicobacter Pylori Treatment Results in Slovenia in the Period 2013-2015 as a Part of European Registry on Helicobacter Pylori Management.

Tepes B, Kastelic M, Vujasinovic M, Lampic P, Seruga M, Jurecic NB, Nyssen OP, Donday MG, O'Morain C, Megraud F, McNicholl AG, Gisbert JP.

Radiol Oncol. 2017 Dec 7;52(1):1-6. doi: 10.1515/raon-2017-0055. eCollection 2018 Mar.

25.

Evaluation of the Diagnostic Accuracy of Two Immunochromatographic Tests Detecting Campylobacter in Stools and Their Role in Campylobacter Infection Diagnosis.

Bessède E, Asselineau J, Perez P, Valdenaire G, Richer O, Lehours P, Mégraud F.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01567-17. doi: 10.1128/JCM.01567-17. Print 2018 Apr.

26.

Gastroenterology today: between certainties and news.

Pellicano R, Ribaldone DG, Astegiano M, Dughera L, Battaglia E, Morgando A, Arrigoni A, Spandre M, Grassini M, Saracco GM, Mégraud F.

Minerva Gastroenterol Dietol. 2018 Dec;64(4):323-332. doi: 10.23736/S1121-421X.18.02465-0. Epub 2018 Jan 10.

27.

A Potential New Human Pathogen Belonging to Helicobacter Genus, Identified in a Bloodstream Infection.

van der Mee-Marquet NL, Bénéjat L, Diene SM, Lemaignen A, Gaïa N, Smet A, Haesebrouck F, Cherkaoui A, Ducournau A, Lacomme S, Gontier E, Bernard L, Mégraud F, Goudeau A, Lehours P, François P.

Front Microbiol. 2017 Dec 18;8:2533. doi: 10.3389/fmicb.2017.02533. eCollection 2017.

28.

New cancer cases in France in 2015 attributable to infectious agents: a systematic review and meta-analysis.

Shield KD, Marant Micallef C, de Martel C, Heard I, Megraud F, Plummer M, Vignat J, Bray F, Soerjomataram I.

Eur J Epidemiol. 2018 Mar;33(3):263-274. doi: 10.1007/s10654-017-0334-z. Epub 2017 Dec 6.

PMID:
29214413
29.

Distinct Campylobacter fetus lineages adapted as livestock pathogens and human pathobionts in the intestinal microbiota.

Iraola G, Forster SC, Kumar N, Lehours P, Bekal S, García-Peña FJ, Paolicchi F, Morsella C, Hotzel H, Hsueh PR, Vidal A, Lévesque S, Yamazaki W, Balzan C, Vargas A, Piccirillo A, Chaban B, Hill JE, Betancor L, Collado L, Truyers I, Midwinter AC, Dagi HT, Mégraud F, Calleros L, Pérez R, Naya H, Lawley TD.

Nat Commun. 2017 Nov 8;8(1):1367. doi: 10.1038/s41467-017-01449-9.

30.

Prevalence, antibiotic resistance, and MLST typing of Helicobacter pylori in Algiers, Algeria.

Raaf N, Amhis W, Saoula H, Abid A, Nakmouche M, Balamane A, Ali Arous N, Ouar-Korichi M, Vale FF, Bénéjat L, Mégraud F.

Helicobacter. 2017 Dec;22(6). doi: 10.1111/hel.12446. Epub 2017 Oct 16.

PMID:
29035009
31.

Antioxidant activities, anticancer activity and polyphenolics profile, of leaf, fruit and stem extracts of Pistacia lentiscus from Tunisia.

Yemmen M, Landolsi A, Ben Hamida J, Mégraud F, Trabelsi Ayadi M.

Cell Mol Biol (Noisy-le-grand). 2017 Sep 30;63(9):87-95. doi: 10.14715/cmb/2017.63.9.16.

PMID:
28980927
32.

Diagnosis of Helicobacter pylori infection.

Bessède E, Arantes V, Mégraud F, Coelho LG.

Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12404. Review.

PMID:
28891135
33.

30th anniversary of the European helicobacter & microbiota study group!

Mégraud F.

Helicobacter. 2017 Sep;22 Suppl 1. doi: 10.1111/hel.12422. No abstract available.

PMID:
28891134
34.

Isolation and Identification of Campylobacter spp. from Poultry and Poultry By-Products in Tunisia by Conventional Culture Method and Multiplex Real-Time PCR.

Jribi H, Sellami H, Mariam S, Smaoui S, Ghorbel A, Hachicha S, Benejat L, Messadi-Akrout F, Mégraud F, Gdoura R.

J Food Prot. 2017 Oct;80(10):1623-1627. doi: 10.4315/0362-028X.JFP-16-321.

PMID:
28853632
35.

Metformin targets gastric cancer stem cells.

Courtois S, Durán RV, Giraud J, Sifré E, Izotte J, Mégraud F, Lehours P, Varon C, Bessède E.

Eur J Cancer. 2017 Oct;84:193-201. doi: 10.1016/j.ejca.2017.07.020. Epub 2017 Aug 17.

PMID:
28822889
36.

Time to change approaches to Helicobacter pylori management.

Mégraud F.

Lancet Gastroenterol Hepatol. 2017 Oct;2(10):692-693. doi: 10.1016/S2468-1253(17)30245-5. Epub 2017 Aug 7. No abstract available.

PMID:
28781120
37.

The Cytolethal Distending Toxin Subunit CdtB of Helicobacter hepaticus Promotes Senescence and Endoreplication in Xenograft Mouse Models of Hepatic and Intestinal Cell Lines.

Péré-Védrenne C, Prochazkova-Carlotti M, Rousseau B, He W, Chambonnier L, Sifré E, Buissonnière A, Dubus P, Mégraud F, Varon C, Ménard A.

Front Cell Infect Microbiol. 2017 Jun 30;7:268. doi: 10.3389/fcimb.2017.00268. eCollection 2017.

38.

Prevalence of faecal carriage of colistin-resistant Gram-negative rods in a university hospital in western France, 2016.

Saly M, Jayol A, Poirel L, Megraud F, Nordmann P, Dubois V.

J Med Microbiol. 2017 Jun;66(6):842-843. doi: 10.1099/jmm.0.000497. Epub 2017 Jun 9.

PMID:
28598315
39.

Deregulation of MicroRNAs in Gastric Lymphomagenesis Induced in the d3Tx Mouse Model of Helicobacter pylori Infection.

Floch P, Capdevielle C, Staedel C, Izotte J, Sifré E, Laur AM, Giese A, Korolik V, Dubus P, Mégraud F, Lehours P.

Front Cell Infect Microbiol. 2017 May 16;7:185. doi: 10.3389/fcimb.2017.00185. eCollection 2017.

40.

Phylogeographic agreement between prophage and bacterial housekeeping genes in Helicobacter pylori strains from The Gambia.

Secka O, Vale FF, Buissonnière A, Thomas JE, Mégraud F, Lehours P.

Helicobacter. 2017 Oct;22(5). doi: 10.1111/hel.12394. Epub 2017 May 22. No abstract available.

PMID:
28544172
41.

Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016).

Jones NL, Koletzko S, Goodman K, Bontems P, Cadranel S, Casswall T, Czinn S, Gold BD, Guarner J, Elitsur Y, Homan M, Kalach N, Kori M, Madrazo A, Megraud F, Papadopoulou A, Rowland M; ESPGHAN, NASPGHAN.

J Pediatr Gastroenterol Nutr. 2017 Jun;64(6):991-1003. doi: 10.1097/MPG.0000000000001594.

PMID:
28541262
42.

A New Animal Model of Gastric Lymphomagenesis: APRIL Transgenic Mice Infected by Helicobacter Species.

Floch P, Izotte J, Guillemaud J, Sifré E, Costet P, Rousseau B, Laur AM, Giese A, Korolik V, Mégraud F, Dubus P, Hahne M, Lehours P.

Am J Pathol. 2017 Jul;187(7):1473-1484. doi: 10.1016/j.ajpath.2017.03.004. Epub 2017 Apr 29.

PMID:
28460208
43.

Helicobacter pylori Strains and Gastric MALT Lymphoma.

Floch P, Mégraud F, Lehours P.

Toxins (Basel). 2017 Apr 8;9(4). pii: E132. doi: 10.3390/toxins9040132. Review.

44.

The Irish Helicobacter pylori Working Group consensus for the diagnosis and treatment of H. pylori infection in adult patients in Ireland.

Smith S, Boyle B, Brennan D, Buckley M, Crotty P, Doyle M, Farrell R, Hussey M, Kevans D, Malfertheiner P, Megraud F, Nugent S, O'Connor A, O'Morain C, Weston S, McNamara D.

Eur J Gastroenterol Hepatol. 2017 May;29(5):552-559. doi: 10.1097/MEG.0000000000000822.

PMID:
28350745
45.

Genomic structure and insertion sites of Helicobacter pylori prophages from various geographical origins.

Vale FF, Nunes A, Oleastro M, Gomes JP, Sampaio DA, Rocha R, Vítor JM, Engstrand L, Pascoe B, Berthenet E, Sheppard SK, Hitchings MD, Mégraud F, Vadivelu J, Lehours P.

Sci Rep. 2017 Feb 16;7:42471. doi: 10.1038/srep42471.

46.

Molecular and Proteomic Analysis of Levofloxacin and Metronidazole Resistant Helicobacter pylori.

Hanafi A, Lee WC, Loke MF, Teh X, Shaari A, Dinarvand M, Lehours P, Mégraud F, Leow AH, Vadivelu J, Goh KL.

Front Microbiol. 2016 Dec 15;7:2015. doi: 10.3389/fmicb.2016.02015. eCollection 2016.

47.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel.

Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

PMID:
27707777
48.

All-trans retinoic acid targets gastric cancer stem cells and inhibits patient-derived gastric carcinoma tumor growth.

Nguyen PH, Giraud J, Staedel C, Chambonnier L, Dubus P, Chevret E, Bœuf H, Gauthereau X, Rousseau B, Fevre M, Soubeyran I, Belleannée G, Evrard S, Collet D, Mégraud F, Varon C.

Oncogene. 2016 Oct 27;35(43):5619-5628. doi: 10.1038/onc.2016.87. Epub 2016 May 9.

PMID:
27157616
49.

Towards effective empirical treatment for Helicobacter pylori eradication.

Megraud F, Gisbert JP.

Lancet. 2016 Nov 12;388(10058):2325-2326. doi: 10.1016/S0140-6736(16)31657-9. Epub 2016 Oct 18. No abstract available.

PMID:
27769561
50.

Deletion of IQGAP1 promotes Helicobacter pylori-induced gastric dysplasia in mice and acquisition of cancer stem cell properties in vitro.

Bessède E, Molina S, Acuña-Amador L, Dubus P, Staedel C, Chambonnier L, Buissonnière A, Sifré E, Giese A, Bénéjat L, Rousseau B, Costet P, Sacks DB, Mégraud F, Varon C.

Oncotarget. 2016 Dec 6;7(49):80688-80699. doi: 10.18632/oncotarget.12486.

Supplemental Content

Loading ...
Support Center